Science Advisory Board

Professor Coen
Clive Coen is Professor of Neuroscience at King’s College London. His multidisciplinary research includes the neuroanatomical analysis of regulatory systems. This is influenced by his longstanding interest in comparative and evolutionary aspects of these systems. He has served on the board of several learned societies and scientific journals and as chief consultant for seven BBC documentaries. Currently he is Editor of Neuroendocrinology and Chair of the Rationalist Association.

Dr Mohs
Richard Mohs is the Chief Scientific Officer for the Global Alzheimer’s Platform (GAP) Foundation. He worked for Eli Lilly and Company holding several leadership positions including Vice President for Neuroscience Early Clinical Development (2012-2015) and Leader of the Global Alzheimer’s Drug Development Team (2007-2012). Dr. Mohs received the Ph.D. is psychology from Stanford University and completed postdoctoral training in pharmacology at the Stanford Medical School.

Professor Herrling
Non-Executive Director

Dr Gary Manchee
Dr Gary Manchee has a PhD on species differences in drug metabolism and he is a co-author on 26 published papers.
Over 30-years’ experience in the pharmaceutical industry and as the Director of Drug Metabolism and Pharmacokinetics in Psychiatry, Respiratory & inflammatory,
and Immuno-inflammatory disease areas within Drug Discovery at GSK, he progressed 35 new compounds into early and late-stage development.